KALA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
KALA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Kala Bio has the GF Value Rank of 4.
The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.
GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).
We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.
After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
For the Biotechnology subindustry, Kala Bio's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Kala Bio's GF Value Rank distribution charts can be found below:
* The bar in red indicates where Kala Bio's GF Value Rank falls into.
Thank you for viewing the detailed overview of Kala Bio's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Todd Bazemore | officer: Chief Operating Officer | C/O DYAX CORP., 55 NETWORK DRIVE, BURLINGTON MA 01803 |
Romulus K Brazzell | officer: Chief Medical Officer | C/O INSPIRE PHARMACEUTICALS, INC., 4222 EMPEROR BLVD., SUITE 200, DURHAM NC 27703 |
Eric Trachtenberg | officer: See Remarks | 1414 RALEIGH ROAD, SUITE 400, CHAPEL HILL NC 27517 |
Darius Kharabi | officer: CHIEF BUSINESS OFFICER | C/O KALA PHARMACEUTICALS, INC., 490 ARSENAL WAY, SUITE 120, WATERTOWN MA 02472 |
Mark T Iwicki | director, officer: Chief Executive Officer | 84 WATERFORD DRIVE, MARLBOROUGH MA 01752 |
Mary Reumuth | officer: Chief Financial Officer | 100 BEAVER STREET, SUITE 201, WALTHAM MA 02453 |
Marjan Farid | director | C/O KALA PHARMACEUTICALS, INC., 1167 MASSACHUSETTS AVENUE, ARLINGTON MA 02476 |
Ra Capital Healthcare Fund Lp | director, 10 percent owner | 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116 |
Mark S. Blumenkranz | director | C/O 1LIFE HEALTHCARE, INC., ONE EMBARCADERO CENTER, SUITE 1900, SAN FRANCISCO CA 94111 |
Hongming Chen | officer: Chief Scientific Officer | 100 BEAVER STREET, SUITE 201, WALTHAM MA 02453 |
C. Daniel Myers | director | 6120 WINDWARD PARKWAY, SUITE 290, ALPHARETTA GA 30005 |
Gregory Grunberg | director | 100 BEAVER STREET, WALTHAM MA 02453 |
Rajeev M. Shah | director | 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116 |
Peter Kolchinsky | director, 10 percent owner | 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116 |
Ra Capital Management, L.p. | director, 10 percent owner | 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116 |
From GuruFocus
By Value_Insider Value_Insider • 11-28-2022
By sperokesalga sperokesalga • 03-27-2023
By PurpleRose PurpleRose • 07-11-2022
By GuruFocusNews GuruFocusNews • 07-08-2022
By GuruFocusNews GuruFocusNews • 07-02-2022
By GuruFocusNews GuruFocusNews • 06-28-2022
By PurpleRose PurpleRose • 07-12-2022
By Value_Insider Value_Insider • 11-28-2022
By Value_Insider Value_Insider • 10-20-2022
By Value_Insider Value_Insider • 11-01-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.